arXiv Biology
scienceCenter
ProMeta: Few-shot PROTAC-targeted degradation prediction across E3 ligasestranslating…
arXiv:2609.09891v1 Announce Type: cross
Abstract: Proteolysis-targeting chimeras (PROTACs) have emerged as a transformative therapeutic strategy that selectively degrades historically ''undruggable'' targets via the ubiquitin-proteasome system. Despite growing efforts to…
Keywords#E3#Few-shot#Few-shot PROTAC-targeted#ProMeta#cross